PAA 1.43% 17.8¢ pharmaust limited

Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-91

  1. 451 Posts.
    lightbulb Created with Sketch. 85
    It appears you really do not like other posters putting criticism of PAA on here. Its not @Buckland that has put PAA in a position of criticism it is PAA themselves.
    I hold and will keep doing so but I have moved over the years from a position of being confident they will achieve something to hoping.
    I previously objected to bucklands negative narrative of the BOD but quite frankly only in my opinion it s looking like that is a balanced view. When responses to critical view points are responded to with teenage quips or fly to Norway to ask a question in my view those posters start to lose credibility or are really feeling the pressure of defending their position.

    Overall I am staying the course in the hope that one of their irons in the fire actually heat up.
    Last edited by Banastas: 17/07/21
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.8¢
Change
0.003(1.43%)
Mkt cap ! $85.12M
Open High Low Value Volume
18.0¢ 18.0¢ 17.8¢ $24.39K 135.6K

Buyers (Bids)

No. Vol. Price($)
5 152309 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 199259 3
View Market Depth
Last trade - 10.23am 12/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.